Order Article Reprints

Tammaccaro SL, Prigent P, Le Bail J-C, Dos-Santos O, Dassencourt L, Eskandar M, Buzy A, Venier O, Guillemot J-C, Veeranagouda Y, et al. TEAD Inhibitors Sensitize KRAS^G12C Inhibitors via Dual Cell Cycle Arrest in KRAS^G12C-Mutant NSCLC. Pharmaceuticals. 2023; 16(4):553. https://doi.org/10.3390/ph16040553

Tammaccaro, Salvina Laura, Philippe Prigent, Jean-Christophe Le Bail, Odette Dos-Santos, Laurent Dassencourt, Myriam Eskandar, Armelle Buzy, Olivier Venier, Jean-Claude Guillemot, Yaligara Veeranagouda, and et al. 2023. "TEAD Inhibitors Sensitize KRAS^G12C Inhibitors via Dual Cell Cycle Arrest in KRAS^G12C-Mutant NSCLC" Pharmaceuticals 16, no. 4: 553. https://doi.org/10.3390/ph16040553

Tammaccaro, S. L., Prigent, P., Le Bail, J.-C., Dos-Santos, O., Dassencourt, L., Eskandar, M., Buzy, A., Venier, O., Guillemot, J.-C., Veeranagouda, Y., Didier, M., Spanakis, E., Kanno, T., Cesaroni, M., Mathieu, S., Canard, L., Casse, A., Windenberger, F., Calvet, L., ... Valtingojer, I. (2023). TEAD Inhibitors Sensitize KRAS^G12C Inhibitors via Dual Cell Cycle Arrest in KRAS^G12C-Mutant NSCLC. Pharmaceuticals, 16(4), 553. https://doi.org/10.3390/ph16040553